Literature DB >> 32434208

Overexpression of microRNA-136-3p Alleviates Myocardial Injury in Coronary Artery Disease via the Rho A/ROCK Signaling Pathway.

Yongbo Lin1, Hanliang Dan1, Jinguo Lu2.   

Abstract

OBJECTIVE: Coronary artery disease (CAD) is a cardiovascular disease that poses a fatal threat to human health, and the identification of potential biomarkers may help to delineate its pathophysiological mechanisms. Accumulating evidence has implicated microRNAs (miRNAs) in the pathogenesis and development of cardiovascular diseases. The present study aims to identify the expression of miRNA-136-3p (miR-136-3p) in CAD and further investigate its functional relevance in myocardial injury both in vitro and in vivo.
METHODS: Initially, CAD models were induced in rats by high-fat diet and intraperitoneal injection of pituitrin. Next, the effect of overexpressed miR-136-3p on cardiac function and pathological damage in myocardial tissue, cardiomyocyte apoptosis, oxidative stress and inflammatory response were assessed in CAD rats. Rat cardiac microvascular endothelial cells (CMECs) were isolated and cultured by the tissue explant method, and the CMEC injury model was induced by homocysteine (HCY). The function of miR-136-3p in vitro was further evaluated.
RESULTS: miR-136-3p was poorly expressed in the myocardial tissue of CAD rats and CMEC injury models. In vivo assays indicated that overexpressed miR-136-3p could improve cardiac function and alleviate pathological damage in myocardial tissue, accompanied by reduced oxidative stress and inflammatory response. Moreover,in vitro assays suggested that overexpression of miR-136-3p enhanced proliferation and migration while inhibiting apoptosis of HCY-stressed CMECs. Notably, we revealed that EIF5A2 was a target gene of miR-136-3p, and miR-136-3p inhibited EIF5A2 expression and activation of the Rho A/ROCK signaling pathway.
CONCLUSION: In conclusion, the overexpression of miR-136-3p could potentially impede myocardial injury in vitro and in vivo in CAD through the blockade of the Rho A/ROCK signaling pathway, highlighting a potential miR-136-3p functional relevance in the treatment of CAD.
© 2020 The Author(s) Published by S. Karger AG, Basel.

Entities:  

Keywords:  Cardiac microvascular endothelial cells; Coronary artery disease; EIF5A2; MicroRNA-136-3p; Rho A/ROCK signaling pathway

Mesh:

Substances:

Year:  2020        PMID: 32434208     DOI: 10.1159/000505849

Source DB:  PubMed          Journal:  Kidney Blood Press Res        ISSN: 1420-4096            Impact factor:   2.687


  6 in total

1.  MicroRNA-136-5p protects cardiomyocytes from coronary microembolization through the inhibition of pyroptosis.

Authors:  Ruping Cai; Yuli Xu; Yanling Ren; Shirong He; Jing Zheng; Binghui Kong; Quanzhong Li; Xiheng Yang; Rixin Dai; Riming Wei; Qiang Su
Journal:  Apoptosis       Date:  2022-01-27       Impact factor: 4.677

Review 2.  Role of MicroRNAs in the Pathogenesis of Coronary Artery Disease.

Authors:  Soudeh Ghafouri-Fard; Mahdi Gholipour; Mohammad Taheri
Journal:  Front Cardiovasc Med       Date:  2021-04-12

3.  Plasma miR-9-3p and miR-136-3p as Potential Novel Diagnostic Biomarkers for Experimental and Human Mild Traumatic Brain Injury.

Authors:  Shalini Das Gupta; Robert Ciszek; Mette Heiskanen; Niina Lapinlampi; Janne Kukkonen; Ville Leinonen; Noora Puhakka; Asla Pitkänen
Journal:  Int J Mol Sci       Date:  2021-02-04       Impact factor: 5.923

Review 4.  Oxidative Stress in Ischemic Heart Disease.

Authors:  Aleksandar Kibel; Ana Marija Lukinac; Vedran Dambic; Iva Juric; Kristina Selthofer-Relatic
Journal:  Oxid Med Cell Longev       Date:  2020-12-28       Impact factor: 6.543

5.  MicroRNA Alterations Induced in Human Skin by Diesel Fumes, Ozone, and UV Radiation.

Authors:  Giuseppe Valacchi; Erika Pambianchi; Simona Coco; Alessandra Pulliero; Alberto Izzotti
Journal:  J Pers Med       Date:  2022-01-28

6.  CircZNF609 Aggravated Myocardial Ischemia Reperfusion Injury via Mediation of miR-214-3p/PTGS2 Axis.

Authors:  Wen-Qiang Tang; Feng-Rui Yang; Ke-Min Chen; Huan Yang; Yu Liu; Bo Dou
Journal:  Korean Circ J       Date:  2022-09       Impact factor: 3.101

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.